Calculation of infectious viral titers represents a basic and essential experimental approach for virologists. Classical plaque assays cannot be used for viruses that do not cause significant cytopathic effects, which is the case for strains 229E and OC43 of human coronavirus (HCoV). An alternative indirect immunoperoxidase assay (IPA) is herein described for the detection and titration of these viruses. Susceptible cells are inoculated with serial logarithmic dilutions of samples in a 96-well plate. After viral growth, viral detection by IPA yields the infectious virus titer, expressed as "Tissue Culture Infectious Dose" (TCID 50 ). This represents the dilution of a virus-containing sample at which half of a series of laboratory wells contain replicating virus. This technique is a reliable method for the titration of HCoV in biological samples (cells, tissues, or fluids).
Introduction
HCoV were first isolated in the mid-1960s from patients with upper respiratory tract disease (1-3). As described by McIntosh (4), the identification of coronaviruses in clinical samples was a very difficult task until the 1970s, as HCoV induced subtle or nonexistent cytopathic effects, and many cells types were not susceptible to the virus. Commonly, HCoV-OC43 (ATCC: VR-759) C Humana Press, New York, NY 8,  was grown and maintained on BS-C-1 (ATCC: CCL-26), RD (ATCC: CCL-136) or HRT-18 (also called HCT-8; ATCC: CCL-224) cell lines. On the other hand, HCoV-229E (ATCC: VR-740) was grown and maintained on WI-38 (ATCC: CCL-75), MRC-5 (ATCC: CCL-171) or L-132 (ATCC: CCL-5) cell lines. Interestingly, cells from the central nervous system (CNS) were reported to be highly susceptible to HCoV replication. The SK-N-SH (ATCC: HTB-11) neuroblastoma and H4 (ATCC: HTB-148) neuroglioma cell lines were highly susceptible to infection, as well as astrocytoma cell lines U-87 MG (ATCC: HTB-14), U-373 MG, and GL-15 (5-8). Even though it was reported that HCoV-229E infectious titers could be determined by plaque assay on specific cell lines, such as MRC-5 or L-132 (6), this proved not to be a reliable assay and, as for HCoV-OC43, an alternative assay was required: an indirect immunoperoxidase assay (IPA) on coronavirus-susceptible cells to quantify infectious virus in biological samples.
The immunoperoxidase assay is an enzymatic antigen detection technique that uses the enzyme horseradish peroxidase (HRP) to label antigen-antibody complexes. The principle of the IPA technique is that a specific antibody recognizes and binds to its specific antigen to yield an antibody-antigen complex. For detection of these complexes, the primary antibody is either directly labeled with HRP or remains unlabeled, with detection achieved by a labeled secondary antibody. If a secondary antibody is used, it must be generated against the immunoglobulins of the animal species in which the primary antibody was produced. The enzyme substrate, 3,3'-diaminobenzidine (DAB) is then converted by HRP to a precipitating brown end-product. 
Methods

Preparation of Tissue Samples
Preparation of Cell Samples
Adherent Cells
To determine extracellular viral production, collect supernatants in sterile tubes from infected cells (to be tested) at appropriate times following infection. For estimation of intracellular viral titers, remove medium, wash cells in warm (37 • C) sterile PBS, then add the same volume or a known volume of medium and perform three cycles of freeze/thaw at -80 • C to lyse cells and release viral particles in the medium. 2. Collect medium samples in sterile tubes, centrifuge for 5 min at 1000 × g. 3. Collect supernatants in new sterile tubes and process to IPA detection, or immediately freeze at -80 • C and store until assayed.
Nonadherent Cells
1. Centrifuge nonadherent cells at 1000 × g for 5 min.
2. Collect supernatants in sterile tubes; they represent the extracellular portion of infectious virus. 3. Resuspend the cell pellet in the same volume (corresponding to the supernatant) or in a known volume of culture medium. 4. Perform three cycles of freeze/thaw at -80 • C to lyse cells and release the viral particles in the medium; they represent the intracellular portion of the infectious virus. 5. Centrifuge for 5 min at 1000 × g. 6. Collect supernatants in new sterile tubes and process to IPA detection, or immediately freeze at -80 • C and store until assayed.
Preparation of Susceptible Cells
To verify the productivity of HCoV infection in biological samples, an immunoperoxidase assay is performed on coronavirus-susceptible cells. Suspensions of susceptible cells are prepared from confluent monolayers by trypsin treatment (trypsin [0.25% (w/v)] for the L132 cell line or trypsin/EDTA [0.05% (w/v)] for the HRT-18 cell line). Trypsin is then inactivated by the addition of culture medium supplemented by 10% (v/v) with fetal bovine serum (FBS). Susceptible cells are plated in a 96-well plate for tissue culture using a multichannel pipette. Dispense 100 l/well of cell suspension as follows.
• HCoV-229E: L-132 cells are seeded at 70,000 cells/ml if inoculation of samples is to be performed 2 days later or 50,000 cells/ml if inoculation of samples is to be performed 3 days later, in alpha-MEM supplemented with 10% (v/v) FBS. Incubate at 37 • C in a humid atmosphere containing 5% (v/v) CO 2 . • HCoV-OC43: HRT-18 cells are plated at 70,000 cells/ml if inoculation of samples is to be performed 3 days later or 50,000 cells/ml if inoculation of samples is to be performed 4 days later, in alpha-MEM supplemented with 10% (v/v) FBS. Incubate at 37 • C in a humid atmosphere containing 5% (v/v) CO 2 .
Immunoperoxidase Assay
Infection of Susceptible Cells with Samples to Be Tested
1. When susceptible cells (L-132 for HCoV-229E or HRT-18 for HCoV-OC43) are at 70-80% confluence in the laminar flow hood, flick the medium of the 96-well plate. Remove residual medium by wrapping each plate in a sterile paper tissue and gently flicking it face down onto sterile paper. 2. Add 100 l of alpha-MEM supplemented with 1% (v/v) FBS to each well. 3 . Each sample should be tested in four adjacent columns in the same plate. Put 100 l/well of aliquots to be tested in the first row. 4. Inoculate with serial logarithmic dilutions of infected samples: Add 11 l/well of the same sample again in four wells in the second row of the 96-well plate. Mix with a multichannel pipette by pipetting up and down in the pipette tip three times and transfer 11 l/well in the third row and so forth to the last row of the plate (Fig. 1) . Change tips after every dilution and discard the remaining 11 l. 
Virus Detection
1. Remove medium completely by flicking the plates onto nonsterile paper towels in the laminar flow hood and delicately rinse the cells by gently filling the wells with PBS with a multichannel pipette. Flick the PBS and remove residual PBS by wrapping each plate in a paper tissue. 2. Fix cells with 100% methanol containing 0.3% (v/v) hydrogen peroxide for 15-30 min at room temperature. 3. Remove fixative by flicking the plates over a sink and remove the residual liquid by flicking it face down onto several paper towels lying on the bench top and then let it totally air-dry, face up for approximately 15-30 min. 4. Prepare an antibody solution specific to the virus at the appropriate dilution in PBS. Add 100 l of specific viral-antibody to each well and incubate plates for 2 h at 37 • C. 5. Completely remove the medium by flicking it over a sink. Rinse the plate by filling the wells with PBS. Flick the PBS into the sink and rinse with PBS twice more, flicking the PBS into the sink after each rinse. Remove residual PBS by flicking it face down onto nonsterile paper towels lying on the bench top. 6. Add 100 l to each well of secondary antibody at 1/1000 dilution in PBS. 7. Incubate plate for 2 h at 37 • C without CO 2 (see Note 3). 8. 30 min before the end of incubation, prepare a solution of DAB (detection reagent). 9. Rinse the plate three times in PBS as in step 5. 10. Add 100 l of developing reagent, DAB solution in PBS, with 0.01% (v/v) hydrogen peroxide to each well and incubate 10-20 min at room temperature, or until the positive control is stained. 
11.
Stop the reaction with one wash with water as in step 5 and fill each well with 100 l deionized water. 12. Read plates with a light microscope to quantify all wells presenting stained cell (Fig. 2) 
Determination of Titers
Infectious virus titers (tissue culture infectious dose at 50%, TCID 50 ) are calculated by the Karber method (11):
where D = -log 10 of the last dilution showing 100% (4 wells/4 wells) of virus positive wells; d = -log 10 of dilution factor. Example: -log 10 10 = -1.0; S = number of all wells presenting virus, including those showing 100% of viral positive wells; this last one representing the unit and other dilutions being a fraction of this unit. For an example see Fig. 3 (also see Note 4). .5] = 2 + 1.5 = 3.5 log 10 (in 100 l as each well contain 100 l) The infectious titer of sample 1 is 4.5 log 10 /ml or 10 4.5 TCID 50 /ml. For organs or intracellular viral titers, keep in mind the dilution factor used. Normally tissue samples are diluted at 10% (w/v), so virus titers will be multiplied by 10. In example 1, the virus titer would be 10 5.5 TCID 50 /ml.
Notes
1. This protocol can be adapted for many other cell culture systems. HCoV-229E could be grown in normal human fetal lung fibroblast cells MRC-5 (ATCC: CCL-171) or Huh7 (12) and HCoV-OC43 in African green monkey kidney cells
